BRCA1 and cancer: Studies also have found synergistic antitumor effects of ATR inhibitors with immunotherapy and other anticancer drugs.733 ATR inhibitors in combination with PARP inhibitors are used in the treatment of tumors with BRCA1/2 mutations.733,1266 Exploiting combination therapy based on ATR inhibitors may be a promising strategy for cancer therapy.